English中文

Offstream
news



Changes

  1. Sanofi and GSK delays a launch of adjuvarned recombinant protein-based of COVID-19 vaccine programme until end of 2021.
  2. Sanofi and GlaxoSmithKline delays a launch of adjuvarned recombinant protein-based of COVID-19 vaccine programme until end of 2021.
  3. Sanofi and GlaxoSmithKline delays a launch of adjuvanted recombinant protein-based of COVID-19 vaccine programme until end of 2021.

Related